Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
48-Hour Action Plan: Patient Safety First, Managed Transparency Second Core Decision (Stated Up Front) We report to regulators immediately—voluntarily—and we disclose on the earnings call. The math is brutal and clear: ~500 patients could develop liver failure over 5 years at current prescribing rates (4M ÷ 8,000).Read the full answer
CEO Action Plan: 48-Hour Crisis Response to Undisclosed Liver Failure Risk Objective: Protect patient safety, uphold ethical and legal obligations, mitigate long-term reputational and financial damage, maintain regulatory trust, and safeguard employee morale—all while navigating immense pressure.Read the full answer